-+ 0.00%
-+ 0.00%
-+ 0.00%

Rein Therapeutics Q4 Adj. EPS $(0.11) Beats $(0.24) Estimate

Benzinga·03/26/2026 21:55:29
Listen to the news
Rein Therapeutics (NASDAQ:RNTX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.24) by 54.17 percent. This is a 94.18 percent increase over losses of $(1.89) per share from the same period last year.